General
European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns
Several European countries are considering mixing COVID-19 vaccines for citizens who received a first dose of AstraZeneca’s shot, an unprecedented move highlighting the challenge for governments struggling to tame rising infections.
Key points:
- Concerns over the safety of the AstraZeneca vaccine have led to countries pausing their rollout
- Some people who received their first COVID-19 shot, are no longer eligible to receive the second
- There is no evidence that mixing vaccines will be as effective against COVID-19
Vaccination programs have been disrupted after a small number of reports that recipients of the AstraZeneca inoculation suffered extremely rare blood clots, leading some countries worldwide to suspend its use out of caution.
Those…
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General5 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General22 hours agoPope Leo XIV urges Hollywood actors to resist algorithms and save neighbourhood cinemas
-
Business21 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI